Kiora Pharmaceuticals (KPRX) Preferred Dividend Payments (2015)
Kiora Pharmaceuticals' (KPRX) quarterly Preferred Dividend Payments came in at $8.2 million in Q1 2015.
Analysis
Kiora Pharmaceuticals (KPRX) Preferred Dividend Payments (2015) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has reported Preferred Dividend Payments for 1 consecutive years, with $8.2 million the latest figure, recorded in Q1 2015.
- For the quarter ending Q1 2015, Preferred Dividend Payments changed N/A year-over-year to $8.2 million; the trailing twelve-month figure through Dec 2015 stood at $8.2 million (changed N/A YoY), and the FY2015 full-year result was $8.2 million, changed N/A from the prior year.
- Preferred Dividend Payments was little changed at $8.2 million in Q1 2015 per KPRX's latest filing.
- Across five years, Preferred Dividend Payments topped out at $8.2 million in Q1 2015 and bottomed at $8.2 million in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Kiora Pharmaceuticals | 15.51 Mn | 15.51 Mn | - | - |